Ditchcarbon
  • Customers
  1. Organizations
  2. Corium, LLC
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 15 days ago

Corium, LLC

Company website

Corium, LLC, headquartered in the United States, is a leading innovator in the pharmaceutical industry, specialising in advanced drug delivery systems. Founded in 2010, the company has made significant strides in developing unique transdermal and microneedle technologies that enhance patient compliance and therapeutic efficacy. With a focus on transforming the way medications are administered, Corium's core products include its proprietary transdermal patches and microneedle arrays, which stand out for their precision and effectiveness. The company operates primarily in North America, with a growing presence in international markets. Recognised for its commitment to quality and innovation, Corium has achieved notable milestones, including strategic partnerships with major pharmaceutical firms. This positions Corium, LLC as a key player in the evolving landscape of drug delivery solutions, dedicated to improving patient outcomes through cutting-edge technology.

DitchCarbon Score

How does Corium, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Corium, LLC's score of 26 is lower than 50% of the industry. This can give you a sense of how well the company is doing compared to its peers.

50%

Let us know if this data was useful to you

Corium, LLC's reported carbon emissions

In 2023, Corium, LLC reported total carbon emissions of approximately 12,297,884 kg CO2e. The breakdown of these emissions includes Scope 1 emissions at about 19,643,000 kg CO2e, Scope 2 emissions at approximately 45,485,000 kg CO2e, and Scope 3 emissions at about 15,904 kg CO2e. Within Scope 3, significant contributors include upstream transportation and distribution at approximately 9,330,593 kg CO2e and fuel and energy-related activities at about 1,940,296 kg CO2e. Despite the substantial emissions figures, Corium, LLC has not disclosed any specific reduction targets or initiatives as part of their climate commitments. There are no emissions data cascaded from a parent or related organisation, indicating that all reported figures are directly from Corium, LLC. The company has not participated in initiatives such as the Science Based Targets initiative (SBTi) or made any climate pledges. Overall, while Corium, LLC has provided detailed emissions data for 2023, their climate strategy appears to lack defined reduction targets or commitments, placing them in a challenging position within the industry context of increasing climate accountability.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2023
Scope 1
19,643,000
Scope 2
45,485,000
Scope 3
15,903.67

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Corium, LLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Corium, LLC is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Corium, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

DMK Pharmaceuticals Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Talphera, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Supernus Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 5 hours ago

Takeda

JP
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Janssen

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250917.4
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy